M-CKD:一种多模式的多教师对比的知识蒸框架,用于预测患有动脉样硬化患者的存活率
Nana Jia1, Tong Jia2, Zhiao Zhang1
1College of Information Science and Engineering, Northeastern University, Shenyang 110819, Liaoning, China.
概括
一个新的框架,M3T-CKD,有效地融合了超声波图像和临床数据,以预测动脉样硬化患者的生存率. 这种方法改善了心血管疾病风险评估和患者的治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 医学成像分析 医学成像分析
- 心血管疾病研究研究
背景情况:
- 动脉样硬化带来了显著的心血管疾病风险,需要改善患者生存预测.
- 目前的生存预测方法在有效地融合多模式数据 (超声波图像,临床数据) 和准确的斑块细分方面面临挑战.
- 通过超声波进行精确的斑块表征对于预测患者的结果至关重要.
研究的目的:
- 开发一种先进的框架,以提高心脏动脉样硬化患者的生存预测.
- 为了应对多模式数据融合和超声波图像中精确的斑块细分的挑战.
- 为了利用知识蒸来改善生存预测中的特征学习.
主要方法:
- 提出了一个多模式多教师对比的知识蒸 (M3T-CKD) 框架.
- 引入了一种模式特征解 (MFD) 模块,用于融合超声波和临床数据中的共享和特定特征.
- 实施了空间道脱学习方案,以改善斑块细分和对比知识蒸 (CKD) 模块,用于特定任务的特征学习.
主要成果:
- M3T-CKD框架在生存预测方面实现了94.79%的高精度.
- 实验结果证明了拟议的MFD和CKD模块的有效性.
- 拟议的方法优于现有的最先进的方法在多模态动脉超声数据集上.
结论:
- 通过有效地整合多模式数据,M3T-CKD提供了一个强大的解决方案,用于预测动脉样硬化中的存活率.
- 该框架能够从细分和生存任务中学习,从而提高预测准确度.
- 这种方法在改善心血管疾病的临床决策和患者管理方面具有显著的潜力.
更多相关视频
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
22.1K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:26Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36